Desk Note — China DUV Raises Equipment Risk · Jul 27
China’s domestic DUV production raises localization risk for chip-equipment leaders while technical parity and commercial scale remain unproven.
Market Outlooks
Midday Market Check — Monday, July 27, 2026
Midday Market Check for Monday, July 27, 2026. Where the session stands: breadth, sectors, and what moved.
MS Research Note — Franchise Quality Meets an Evidence Gap
Morgan Stanley’s improving returns support its franchise, while relative weakness and an unresolved wealth-margin bridge raise the evidence bar.
MS Deep Coverage Review — Analysis as of July 27, 2026
Morgan Stanley’s improving returns support its premium mix, while relative weakness and an unverified wealth-margin bridge keep the thesis contested.
CAMS Market Minute — Week of July 27, 2026
CAMS Market Minute for Monday, July 27, 2026. The week ahead in under four minutes, from the CAMS Weekly Outlook.
UNH Research Note — Better Headlines, Unresolved Costs
UnitedHealth’s better quarter did not settle the medical-cost debate as the shares reversed sharply despite broader health-care leadership.
UNH Deep Coverage Review — Analysis as of July 27, 2026
UnitedHealth’s valuation and dividend support the franchise, but medical-cost uncertainty and a failed breakout leave stabilization unconfirmed.
Morning Market Brief — Monday, July 27, 2026
Morning Market Brief for Monday, July 27, 2026. Index futures, the overnight tape, and the calendar that matters today.
Market Structure: Inflation Pressure Reshapes Leadership — July 27, 2026
Energy, health care, and financials lead as higher-rate expectations pressure consumer and communication groups across the current market tape.
LLY Research Note — Franchise Strength Meets Valuation Risk
Lilly’s incretin franchise remains powerful, while valuation, policy and access risks make the August 5 evidence window unusually important.